| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 23.73▲ | 23.70▲ | 23.73▲ | 23.31▲ | 23.85▼ |
| MA10 | 23.69▲ | 23.63▲ | 23.59▲ | 23.26▲ | 24.87▼ |
| MA20 | 23.57▲ | 23.55▲ | 23.54▲ | 23.72▲ | 26.03▼ |
| MA50 | 23.50▲ | 23.33▲ | 23.31▲ | 25.07▼ | 27.75▼ |
| MA100 | 23.41▲ | 23.43▲ | 23.88▼ | 26.22▼ | 32.18▼ |
| MA200 | 23.31▲ | 24.30▼ | 24.71▼ | 27.65▼ | 45.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.023▲ | 0.020▲ | 0.029▲ | 0.102▲ | -0.254▼ |
| RSI | 62.469▲ | 59.113▲ | 58.802▲ | 46.585▼ | 36.011▼ |
| STOCH | 70.370 | 82.156▲ | 72.949 | 61.663 | 18.401▼ |
| WILL %R | -22.449▲ | -21.154▲ | -21.154▲ | -15.442▲ | -78.197▼ |
| CCI | 76.321 | 91.440 | 83.567 | 126.425▲ | -108.839▼ |
| CDL | $ACES Harami Candlestick Pattern Detected | Set Alert |
|
Monday, March 17, 2025 04:58 AM
AstraZeneca's eneboparatide met its Phase 3 trial goal for chronic hypoparathyroidism, while the EU approved Imfinzi for small cell lung cancer treatment.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/03/25 | 23.44 | 23.854 | 23.44 | 23.73 | 55,145 |
| 18/03/25 | 23.50 | 23.56 | 23.35 | 23.38 | 115,108 |
| 17/03/25 | 23.07 | 23.745 | 23.07 | 23.62 | 32,881 |
| 14/03/25 | 23.03 | 23.1401 | 22.98 | 23.05 | 60,194 |
| 13/03/25 | 23.01 | 23.26 | 22.6018 | 22.76 | 20,172 |
| 12/03/25 | 23.37 | 23.37 | 22.95 | 23.11 | 48,166 |
| 11/03/25 | 23.22 | 23.385 | 22.70 | 23.09 | 82,414 |
| 10/03/25 | 23.28 | 23.715 | 22.98 | 23.19 | 119,186 |
| 07/03/25 | 22.98 | 23.605 | 22.98 | 23.53 | 95,277 |
| 06/03/25 | 22.91 | 23.21 | 22.8019 | 23.0904 | 21,530 |
|
|
||||
|
|
||||
|
|